Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)

A Multicenter, Non-comparative, Phase IV Study to Evaluate the Effect of Candesartan Based Therapy in the Percent Change of proBNP Level After 24 Week Treatment in the Patients With Hypertension With Left Ventricular Hypertrophy

The purpose of this study is to investigate effect of candesartan based therapy on percent change of B type natriuretic peptides(BNP) level in the subjects with hypertension and left ventricular hypertrophy.

Inclusion Criteria:

• Hypertension with diastolic blood pressure within 95-115 mm/Hg or/and systolic blood pressure within 160-200 mm/Hg
• Patients diagnosed as left ventricular hypertrophy by electrocardiogram

Exclusion Criteria:

• Secondary hypertension
• History of myocardial infarction
• Stroke within the previous 6 months